Pfizer just got a reality check from one of Wall Street’s biggest banks, and the timing could not be more awkward heading into the second half of the year. HSBC downgraded Pfizer to Hold from Buy on Monday, trimming its price target to $28 from $32. Analyst Rajesh Kumar pointed to reduced confidence in any […] The post Pfizer (PFE) stock: the warning sign investors cant ignore appeared first on Rolling Out .
Install the app today!
Get in touch with us
Reach out to the Hayti team about
collaborating or working together.